Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Cirrus Logic Expands Pro Audio Portfolio with New Range of ADCs and DACs
Cirrus Logic Expands Pro Audio Portfolio with New Range of ADCs and DACs


Cirrus Logic (Nasdaq: CRUS), a leader in innovative audio technology, today announced the launch of its latest additions to the Pro Audio product family: two analog-to-digital converters (ADCs) and

Redfin Reports 6% of Today’s Home Sellers Are at Risk of Selling at a Loss
Redfin Reports 6% of Today’s Home Sellers Are at Risk of Selling at a Loss


(NASDAQ: RDFN) — Nearly 6% of today’s U.S. home sellers are at risk of selling for less than their purchase price—up from 4.4% a year ago, but still well below pre-pandemic levels—according to a

Piper Sandler Strengthens Insurance Investment Banking Team with the Addition of Alex Ring
Piper Sandler Strengthens Insurance Investment Banking Team with the Addition of Alex Ring


Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Alex Ring as a managing director to its insurance investment banking team. He will be based

Hancock Whitney Corporation to Announce Second Quarter 2025 Financial Results and Host Conference Call July 15
Hancock Whitney Corporation to Announce Second Quarter 2025 Financial Results and Host Conference Call July 15


Hancock Whitney Corporation (Nasdaq: HWC) will announce second quarter 2025 financial results on Tuesday, July 15, 2025 after the market closes. Management will host a conference call for analysts

2024 Interface Impact Report Highlights Continued Climate Progress, Purpose-Driven Culture Investments
2024 Interface Impact Report Highlights Continued Climate Progress, Purpose-Driven Culture Investments


Interface, Inc. (NASDAQ: TILE), the global flooring solutions company and leader in sustainability, today released its 2024 Impact Report. The report outlines the company’s commitment to

Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
Affluent Medical : Affluent Medical extends the horizon of its cash position to end-2025 with support from its key shareholders
EQS-News: Successful Virtual Annual General Meeting: Ringmetall SE Reports from Munich
EQS-News: Successful Virtual Annual General Meeting: Ringmetall SE Reports from Munich
EQS-News: Successful Virtual Annual General Meeting: Ringmetall SE Reports from Munich
Charwood Energy: Energy&+ asserts its position as an equipment supplier with a new project to install boilers for the district heating network in Gaillac (Tarn)   
Charwood Energy: Energy&+ asserts its position as an equipment supplier with a new project to install boilers for the district heating network in Gaillac (Tarn)  
Charwood Energy: Energy&+ asserts its position as an equipment supplier with a new project to install boilers for the district heating network in Gaillac (Tarn)  
FICO Score Mortgage Simulator Integration with MeridianLink Mortgage Credit Link Enables Resellers and Lenders to Analyze Loan Options
FICO Score Mortgage Simulator Integration with MeridianLink Mortgage Credit Link Enables Resellers and Lenders to Analyze Loan Options


FICO (NYSE: FICO):



Highlights:




  • FICO® Score Mortgage Simulator gives mortgage professionals the ability to simulate how changes in an applicant’s credit report data can impact their FICO®

TD SYNNEX Reports Fiscal 2025 Second Quarter Results
TD SYNNEX Reports Fiscal 2025 Second Quarter Results


TD SYNNEX (NYSE: SNX) today announced financial results for the fiscal second quarter ended May 31, 2025.



“Our Q2 results demonstrate the continued strength of the IT Distribution and

Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease
Sangamo Therapeutics Announces Positive Topline Results From Registrational STAAR Study in Fabry Disease


Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced positive topline results from the registrational Phase 1/2 STAAR study evaluating isaralgagene civaparvovec

EQS-Adhoc: Einhell Germany AG: Termination of CFO's Executive Board Membership
EQS-Adhoc: Einhell Germany AG: Termination of CFO's Executive Board Membership
EQS-Adhoc: Einhell Germany AG: Termination of CFO's Executive Board Membership
Gold Reserve Announces Filing of Emergency Request in CITGO Sale Process Regarding OFAC Issuance of General License 5S
Gold Reserve Announces Filing of Emergency Request in CITGO Sale Process Regarding OFAC Issuance of General License 5S


Gold Reserve Ltd. (TSX.V: GRZ) (OTCQX: GDRZF) (“Gold Reserve” or the “Company”) announces that today it filed an emergency letter request with the U.S. District Court for the District of Delaware

ECS Named a 2025 Top Washington-Area Workplace
ECS Named a 2025 Top Washington-Area Workplace


ECS, a provider of advanced technology solutions in data and AI, cybersecurity, and enterprise transformation, and an ASGN (NYSE: ASGN) brand, has been named one of The Washington Post’s 2025 Top

Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc.
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Aviva plc
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The
Form 8.3 - The Vanguard Group, Inc.: Spectris plc
Form 8.3 - The Vanguard Group, Inc.: Spectris plc
Form 8.3 - The Vanguard Group, Inc.: Spectris plc
AstroNova Letter to Shareholders Highlights Board’s Commitment to Shareholder Value
AstroNova Letter to Shareholders Highlights Board’s Commitment to Shareholder Value


AstroNova, Inc. (Nasdaq: ALOT), a leading innovator in data visualization technology, has published a letter to shareholders outlining shared concerns with Samir Patel and actions that have already

R.E.A. Holdings plc: Notification of Major Holdings
R.E.A. Holdings plc: Notification of Major Holdings
R.E.A. Holdings plc: Notification of Major Holdings
Hardman & Co Research on Volta Finance Limited (VTAS): Volatility put into context
Hardman & Co Research on Volta Finance Limited (VTAS): Volatility put into context
Hardman & Co Research on Volta Finance Limited (VTAS): Volatility put into context
EQS-News: PVA TePla AG: Annual General Meeting confirms strategic course – new Supervisory Board setup
EQS-News: PVA TePla AG: Annual General Meeting confirms strategic course – new Supervisory Board setup
EQS-News: PVA TePla AG: Annual General Meeting confirms strategic course – new Supervisory Board setup
EQS-News: The Platform Group: closing and further acquisition in the optical sector
EQS-News: The Platform Group: closing and further acquisition in the optical sector
EQS-News: The Platform Group: closing and further acquisition in the optical sector
EQS-News: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in  Relapsing-Remitting Multiple Sclerosis
EQS-News: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis
EQS-News: Immunic Reports New, Positive Long-Term Open-Label Extension Data From Phase 2 EMPhASIS Trial of Vidofludimus Calcium in Relapsing-Remitting Multiple Sclerosis